INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.70 Cr | ₹-0.66 Cr | ₹-0.59 Cr | ₹-0.42 Cr | ₹-0.26 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDO US BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.70 Cr |
| Mar2024 | ₹-0.66 Cr |
| Mar2023 | ₹-0.59 Cr |
| Mar2022 | ₹-0.42 Cr |
| Mar2021 | ₹-0.26 Cr |
How is Deferred Tax Assets / Liabilities of INDO US BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.70 Cr | Negative | |
| Mar2024 | ₹-0.66 Cr | Negative | |
| Mar2023 | ₹-0.59 Cr | Negative | |
| Mar2022 | ₹-0.42 Cr | Negative | |
| Mar2021 | ₹-0.26 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹211.4 Cr | 5.2% | -30% | -38.5% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,484.3 Cr | 0.4% | -17.4% | -7.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,185.9 Cr | 0.2% | -3.8% | -31.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,837.2 Cr | 7% | -8.4% | -19.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹823.0 Cr | -3.9% | -15.5% | -36.1% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹344.4 Cr | 4.9% | -13.1% | -29.3% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 5.2% |
-30% |
-38.5% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses